Free Trial

Kazia Therapeutics (KZIA) SEC Filings & 10K Form

Kazia Therapeutics logo
$5.64 -0.07 (-1.23%)
(As of 11/20/2024 ET)

Recent Kazia Therapeutics SEC Filings

DateFilerForm TypeView
11/06/2024
6:53 PM
Kazia Therapeutics (Subject)
PLATINUM INVESTMENT MANAGEMENT LTD (Filed by)
Form SC 13G
11/01/2024
3:05 PM
Kazia Therapeutics (Filer)
Form NT 20-F
10/24/2024
7:28 AM
Kazia Therapeutics (Filer)
Form 424B3
10/24/2024
7:33 AM
Kazia Therapeutics (Filer)
Form 424B3
10/24/2024
7:38 AM
Kazia Therapeutics (Filer)
Form 424B3
10/24/2024
7:22 AM
Kazia Therapeutics (Filer)
Form 6-K/A
10/15/2024
6:01 AM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/15/2024
6:03 AM
Kazia Therapeutics (Filer)
Form 424B3
10/15/2024
6:04 AM
Kazia Therapeutics (Filer)
Form 424B3
10/15/2024
6:06 AM
Kazia Therapeutics (Filer)
Form 424B3
10/02/2024
3:52 PM
Kazia Therapeutics (Filer)
Form 424B3
10/02/2024
3:55 PM
Kazia Therapeutics (Filer)
Form 424B3
10/02/2024
3:57 PM
Kazia Therapeutics (Filer)
Form 424B3
09/23/2024
8:27 AM
Kazia Therapeutics (Filer)
Form 424B3
09/23/2024
8:23 AM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/23/2024
8:25 AM
Kazia Therapeutics (Filer)
Form 424B3
09/23/2024
8:26 AM
Kazia Therapeutics (Filer)
Form 424B3
09/13/2024
8:06 AM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/13/2024
8:10 AM
Kazia Therapeutics (Filer)
Form 424B3
09/13/2024
8:12 AM
Kazia Therapeutics (Filer)
Form 424B3
09/13/2024
8:14 AM
Kazia Therapeutics (Filer)
Form 424B3
09/12/2024
11:15 PM
Kazia Therapeutics (Filer)
Form EFFECT
09/04/2024
7:56 PM
Kazia Therapeutics (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
08/12/2024
6:28 PM
Alumni Capital LP (Filed by)
Kazia Therapeutics (Subject)
Form SC 13G/A
07/10/2024
8:26 AM
Kazia Therapeutics (Filer)
Form 424B3
07/10/2024
8:28 AM
Kazia Therapeutics (Filer)
Form 424B3
07/10/2024
8:28 AM
Kazia Therapeutics (Filer)
Form 424B3
07/10/2024
8:19 AM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/02/2024
4:29 PM
Alumni Capital LP (Filed by)
Kazia Therapeutics (Subject)
Form SC 13G
06/28/2024
3:27 PM
Kazia Therapeutics (Filer)
Form 424B3
06/24/2024
7:14 PM
Kazia Therapeutics (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
06/04/2024
11:15 PM
Kazia Therapeutics (Filer)
Form EFFECT
05/29/2024
7:55 AM
Kazia Therapeutics (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
05/23/2024
6:00 AM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/23/2024
6:03 AM
Kazia Therapeutics (Filer)
Form 424B3
05/01/2024
3:01 PM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/01/2024
3:06 PM
Kazia Therapeutics (Filer)
Form 424B3
04/19/2024
3:26 PM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/19/2024
3:30 PM
Kazia Therapeutics (Filer)
Form 424B3
03/27/2024
7:37 AM
Kazia Therapeutics (Filer)
Form 424B3
03/27/2024
7:26 AM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
[625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Register for the FREE Workshop Now & get $10 in Bitcoin
03/26/2024
7:02 AM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/21/2024
8:19 AM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2024
2:41 PM
ARMISTICE CAPITAL, LLC (Filed by)
Kazia Therapeutics (Subject)
Form SC 13G
02/12/2024
5:35 PM
Kazia Therapeutics (Subject)
PLATINUM INVESTMENT MANAGEMENT LTD (Filed by)
Form SC 13G
02/05/2024
11:15 PM
Kazia Therapeutics (Filer)
Form EFFECT
01/18/2024
3:30 PM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/12/2024
3:05 PM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/25/2023
11:15 PM
Kazia Therapeutics (Filer)
Form EFFECT
12/15/2023
4:26 PM
Kazia Therapeutics (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
12/15/2023
3:49 PM
Kazia Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
12/06/2023
7:31 AM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/01/2023
7:30 AM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/29/2023
3:19 PM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/21/2023
3:09 PM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:KZIA) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners